FDA panel votes against wider use of Amgen drug
WASHINGTON (Reuters) - An advisory panel on Wednesday recommended that U.S. health regulators reject the use of Amgen Inc's drug Xgeva to delay the spread of prostate cancer to the bone, dimming the chance of a wider use for one of the company's key growth drivers. (Source: Reuters: Health)
'Do Your Best' Not A Good Enough Goal to Improve Diabetes Diet
February 8, 2012 (Ohio State University) — A specific goal to eat a set number of daily servings of low-glycemic-index foods can improve dietary habits of people with type 2 diabetes, according to new research.
read more (Source: Diabetes News from dLife.com)
